References
- Fontaine R, Chouinard G: An open clinical trial of fluoxetine in the treatment of obsessive—compulsive disorder. J Clin Psychopharmacol 6:98–101, 1986
- Price, LH, Goodman, WK, Charney, DS, et al: Treat-ment of severe obsessive—compulsive disorder with fluvoxamine. Am J Psychiatry 1:1059–1061, 1987
- Perse, TL, Greist, JH, Jefferson, JW: Fluvoxamine treatment of obsessive—compulsive disorder. Am J Psychiatry 144:1543–1548, 1987
- Goodman, WK, Price, LH, Rasmussen, SA, et al: Ef-ficacy of fluvoxamine in obsessive—compulsive dis-order. Arch Gen Psychiatry 46:36–44, 1989
- Thoren P, Asberg M, Cronholm, et al: Clomipramine treatment of obsessive—compulsive disorder. Arch Gen Psychiatry 37:1281–1294, 1980
- Benkelfat C, Murphy D, Zohar J, et al: Clomipramine in obsessive compulsive disorder. Arch Gen Psychia-try 46:23–28, 1989
- Anarith J, SoIyom L, Bryntwich S. Umashankar K: Clomipramine therapy for obsessive—compulsive neu-rosis. Am Psychiatry 136:5, 1979
- Stroebel CF, Szarek BL, Gluech B: Use of clomipra-mine in treatment of obsessive compulsive symptom-atology. J Clin Psychopharmacol 4:2, 1984
- Deveaugh-Geiss J, Katz RJ, Landau P. et al: A multi-center trial of anafranil in OCD, presented at the APA meeting, Montreal, Canada, 1988
- Foa, EB, Steketee, GL., Kozyk, MJ, et al: Imipramine and placebo in the treatment of obsessive-compul-sives: Their effect on depression and on obsessional symptoms. Psychopharmacol Bull 23:8–11, 1987
- Goodman WK, Charney DS: Therapeutic applications and mechanisms of action of monoamine oxidase in-hibitors and heterocyclic antidepressant drugs. 46:6–22, 1985
- Blier P. De Montigny C, Chaput Y: Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-31S, 1987
- Fuller RW, Wong DT: Serotonin reuptake blockers in vitro and in vivo. J Clin Psychopharmacol 7:36S-43S, 1987
- Richelson E: Antidepressants and brain neurochem-istry. Mayo Clin Proc 65:1227–1236, 1990
- Volavka J, Neziroglu F, Yaryura-Tobias JA: Clomipra-mine and imipramine in obsessive-compulsive dis-order. Psychiatry Res 14:83–91, 1985
- Mavissakalian M, Turner M, Michelson L, et al: Tri-cyclic antidepressants in obsessive-compulsive dis-order: Anti-obsessional or antidepressant agents? II. Am J Psychiatry 192:572–576, 1985
- Quitkin FM, Rabkin JG, Ross D, et al: Duration of anti-depressant drug treatments—What is an ade-quate trial? Arch Gen Psychiatry 41:238–245, 1984
- Goodman WK, Price LH, Rasmussen SA, et al: Yale Brown OCD Scale (YBOC): Part I. Development, use and reliability. Arch Gen Psychiatry 46:1006–1008, 1989
- Fogelson DL, Bystritsky A, Sussman N: Depression and anxiety disorder. Psychiatr Ann 18:158–167, 1988